Neuromodulation technology developer Neuros Medical filed an SEC Form D to confirm the sale of nearly $37 million in equity.
Willoughby Hills, Ohio-based Neuros Medical made the first sale in the new notice offering on Oct. 27, 2020, and listed in the SEC filing that it does not intend for it to last longer than one year. So far, 24 investors have participated in the financing.
The equity offering, which is not being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer, is listed with a total amount of nearly $42.8 million. With the $37 million sold, approximately $5.8 million remains to be sold.
Click here to read the complete story.
Story excerpt provided by Mass Device.
Written by Sean Whooley.
Originally published November 3, 2020.